Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:2323-2332
Published online before print April 20, 2009, doi: 10.1161/CIRCULATIONAHA.108.846634
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
119/17/2323    most recent
CIRCULATIONAHA.108.846634v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brähler, S.
Right arrow Articles by Köhler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brähler, S.
Right arrow Articles by Köhler, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Other Treatment
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

(Circulation. 2009;119:2323-2332.)
© 2009 American Heart Association, Inc.


Hypertension

Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension

Sebastian Brähler*; Anuradha Kaistha, MSc*; Volker J. Schmidt, MD; Stephanie E. Wölfle, PhD; Christoph Busch, MD; Brajesh P. Kaistha, MSc; Michael Kacik, MD; Anna-Lena Hasenau; Ivica Grgic, MD; Han Si, PhD; Chris T. Bond, PhD; John P. Adelman, PhD; Heike Wulff, PhD; Cor de Wit, MD; Joachim Hoyer, MD; Ralf Köhler, PhD

From the Department of Internal Medicine/Nephrology, Philipps University, Marburg, Germany (S.B., A.K., C.B., B.P.K., M.K., A.H., I.G., J.H., R.K.); Department of Physiology, University of Lübeck, Lübeck, Germany (V.J.S., S.E.W., C.d.W.); Division of Nephrology, Albert Einstein College of Medicine, Bronx, NY (H.S.); Vollum Institute, Oregon Health and Science University, Portland (C.T.B., J.P.A.); and Department of Pharmacology, University of California, Davis (H.W.).

Correspondence to Ralf Köhler, PhD, Biomedical Research Center, Hans-Meerweinstrasse, 35037 Marburg, Germany. E-mail rkoehler{at}med.uni-marburg.de

Received December 22, 2008; accepted March 3, 2009.

Background— It has been proposed that activation of endothelial SK3 (KCa2.3) and IK1 (KCa3.1) K+ channels plays a role in the arteriolar dilation attributed to an endothelium-derived hyperpolarizing factor (EDHF). However, our understanding of the precise function of SK3 and IK1 in the EDHF dilator response and in blood pressure control remains incomplete. To clarify the roles of SK3 and IK1 channels in the EDHF dilator response and their contribution to blood pressure control in vivo, we generated mice deficient for both channels.

Methods and Results— Expression and function of endothelial SK3 and IK1 in IK1–/–/SK3T/T mice was characterized by patch-clamp, membrane potential measurements, pressure myography, and intravital microscopy. Blood pressure was measured in conscious mice by telemetry. Combined IK1/SK3 deficiency in IK1–/–/SK3T/T (+doxycycline) mice abolished endothelial KCa currents and impaired acetylcholine-induced smooth muscle hyperpolarization and EDHF-mediated dilation in conduit arteries and in resistance arterioles in vivo. IK1 deficiency had a severe impact on acetylcholine-induced EDHF-mediated vasodilation, whereas SK3 deficiency impaired NO-mediated dilation to acetylcholine and to shear stress stimulation. As a consequence, SK3/IK1-deficient mice exhibited an elevated arterial blood pressure, which was most prominent during physical activity. Overexpression of SK3 in IK1–/–/SK3T/T mice partially restored EDHF- and nitric oxide-mediated vasodilation and lowered elevated blood pressure. The IK1-opener SKA-31 enhanced EDHF-mediated vasodilation and lowered blood pressure in SK3-deficient IK1+/+/SK3T/T (+doxycycline) mice to normotensive levels.

Conclusions— Our study demonstrates that endothelial SK3 and IK1 channels have distinct stimulus-dependent functions, are major players in the EDHF pathway, and significantly contribute to arterial blood pressure regulation. Endothelial KCa channels may represent novel therapeutic targets for the treatment of hypertension.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 2295-2296. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Krotz, N. Hellwig, M. A. Burkle, S. Lehrer, T. Riexinger, H. Mannell, H.-Y. Sohn, V. Klauss, and U. Pohl
A sulfaphenazole-sensitive EDHF opposes platelet-endothelium interactions in vitro and in the hamster microcirculation in vivo
Cardiovasc Res, October 4, 2009; (2009) cvp301v2.
[Abstract] [Full Text] [PDF]